Albion Financial Group UT Reduces Holdings in KORU Medical Systems, Inc. $KRMD

Key Points

• Albion Financial Group UT reduced its stake in KORU Medical Systems by 19.3%, owning 356,374 shares, following the sale of 85,000 shares in the second quarter.
• Several other hedge funds have made adjustments to their positions in KORU Medical, with notable increases from Northern Trust Corp and Jane Street Group LLC.
• KORU Medical Systems reported $10.20 million in revenue for the last quarter, surpassing analysts' expectations and achieving a positive $0.01 EPS amidst a projected -0.13 EPS for the current year.

Albion Financial Group UT cut its stake in KORU Medical Systems, Inc. (NASDAQ:KRMD - Free Report) by 19.3% in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 356,374 shares of the company's stock after selling 85,000 shares during the period. Albion Financial Group UT owned about 0.77% of KORU Medical Systems worth $1,276,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also made changes to their positions in the company. Northern Trust Corp boosted its position in shares of KORU Medical Systems by 11.2% in the 4th quarter. Northern Trust Corp now owns 79,175 shares of the company's stock valued at $305,000 after purchasing an additional 7,967 shares during the period. Jane Street Group LLC boosted its holdings in shares of KORU Medical Systems by 67.0% in the fourth quarter. Jane Street Group LLC now owns 68,923 shares of the company's stock valued at $265,000 after acquiring an additional 27,664 shares during the period. Millennium Management LLC grew its position in shares of KORU Medical Systems by 4.5% during the fourth quarter. Millennium Management LLC now owns 283,710 shares of the company's stock worth $1,092,000 after acquiring an additional 12,187 shares during the last quarter. Jefferies Financial Group Inc. purchased a new position in shares of KORU Medical Systems during the fourth quarter worth approximately $132,000. Finally, Calamos Advisors LLC increased its holdings in shares of KORU Medical Systems by 36.5% in the 1st quarter. Calamos Advisors LLC now owns 88,718 shares of the company's stock valued at $225,000 after acquiring an additional 23,729 shares during the period. Institutional investors and hedge funds own 58.60% of the company's stock.

KORU Medical Systems Stock Up 1.0%

Shares of NASDAQ:KRMD opened at $3.96 on Monday. KORU Medical Systems, Inc. has a 1-year low of $1.86 and a 1-year high of $5.05. The company has a debt-to-equity ratio of 0.01, a current ratio of 2.91 and a quick ratio of 2.25. The stock has a market cap of $183.11 million, a P/E ratio of -44.00 and a beta of 0.57. The firm has a fifty day moving average price of $3.92 and a 200 day moving average price of $3.27.

KORU Medical Systems (NASDAQ:KRMD - Get Free Report) last announced its earnings results on Wednesday, August 6th. The company reported $0.01 EPS for the quarter, beating analysts' consensus estimates of ($0.03) by $0.04. KORU Medical Systems had a negative net margin of 12.24% and a negative return on equity of 26.77%. The business had revenue of $10.20 million during the quarter, compared to analysts' expectations of $9.46 million. Sell-side analysts predict that KORU Medical Systems, Inc. will post -0.13 EPS for the current year.

KORU Medical Systems Profile

KORU Medical Systems, Inc develops and manufactures medical devices and supplies in the United States and internationally. It offers the freedom infusion systems to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases, chronic inflammatory demyelinating polyneuropathy, and paroxysmal nocturnal hemoglobinuria.

Want to see what other hedge funds are holding KRMD? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for KORU Medical Systems, Inc. (NASDAQ:KRMD - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.